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Methods
Anti-TB Data Results, Conclusions, and Further Work
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Dry samples of plant materials were ground into powder and
were extracted in a Soxhlex apparatus with hexane or
dichloromethane for 4-8 hours. The solutions were then
concentrated using a rotavapor, under reduced pressure at about
50-60 o C, until no more solvent would come off, giving crude
residues which were tested for biological activity. The extracted
solid samples were further extracted using methanol at room
temperature. These solutions were subjected to the same
rotavapor technique (above), producing additional crude residues
which were also tested.
For the residues which are described (above) as crude, no
purification was done on any of them, before the biological
testing. Of course the strategy was to try to figure out which ones
(if any) might be worthy of separation into individual compounds,
which could then be tested.
Thus, counter-current chromatography (CCC) was run on two of
the crude sw/usa residues by Dr. Brent Friesen, and one crude
Illinois residue was subjected to open flash column
chromatography (FCC) on silica gel, run by two of the authors
(DA and DF), under the direction of Jordan Gunn, doctoral
candidate at University of Illinois at Chicago. Selected fractions
(from both methods, CCC and FCC) were submitted for biological
testing.
Sample
MABA
MIC [ug/ml] 
LORA
MIC [ug/ml] 
DA-1* 45.8 41.9
DA-19 (fraction 65 
of CCC of DA-1) 47.0
DA-17* >50
DA-3 (fraction 19 
of CCC of DA-17) 48.1
DA-12* 22.7
P8 43.1
*Crude extracts.
We sent crude residues, selected CCC fractions, and one FCC
fraction (P8) to the Institute for Tuberculosis Research, College of
Pharmacy, University of Illinois at Chicago, where they were
tested for anti-tuberculosis activity, as shown in the “ANTI-TB
DATA” table.
As for CCC, which we applied only to the sw/usa samples, and
using one of our active crude samples, DA-1, as an example,
although its MIC (minimum inhibitory concentration) values were
appreciably above those of known anti-TB compounds (RMP,
INH, and PA824) used as “standards” for comparisons, we
submitted DA-1 (a crude residue) to CCC, and had selected
fractions tested for anti-TB activity, to see if one or more of the
fractions had about the same or higher activity than the crude
residue. Since at least one of those fractions, DA-19, had about
the same activity, we expect that it contains at least one of the
active compounds. Therefore, we figure that DA-19 is worthy of
further purification.
We did the same thing with another crude residue, DA-17. One of
its fractions, DA-3, showed higher activity than DA-17. How much
higher we don’t know because (of course) we don’t know how
high “>50” really was (for DA-17) and hence we don’t know how
low its activity really was. DA-3 is also worthy of further
purification. Next, we plan to do the same thing with crude
residue, DA-12.
As for FCC, which we applied only to the plant samples collected
here in Illinois, fraction P8 had anti-TB activity (43.1), but none of
the other FCC fractions had any anti-TB activity. We figure that P8
is worthy of further purification
We also sent crude sw/usa residues to Notre Dame University for
antibacterial testing. Three had activity against one or more of the
bacterial species included in this study, as shown in the
ANTIBACTERIAL DATA table. All samples had values of 256 or
>256 for E. coli, E. aerogenes, A. baumanii, and K. pneumoniae,
so these bacterial species are not included in the table.
Introduction
In a general way, bioactive natural products are dealt with very
well by Liang & Fang, 2006 (See “References” section below.)
More specifically, the southwestern part of the United States has a
large variety of indigenous plants many of which have not been
investigated for their medicinal potential, and only very few have
had their extracts separated into the individual compounds they
may contain. But, some information is available for Native
American herbal uses (Moerman, 2003).
MABA (Microplate Alamar Blue Assay) 
LORA (Low Oxygen Recovery Assay)
Antibacterial Data
Sample S. aureus
P. 
aeruginosa
E. 
faecium
60-1 64 256 64
62-4 32 128 16
64-3 32 128 16
MICs in μg/mL
Standards MIC [uM] MIC [uM] 
RMP 0.04 0.76
INH 0.45 > 128 
PA824 0.91 1.57
Moerman , D. (2003). Unpublished raw data, University of 
Michigan-Dearborn, Dearborn, Michigan. Retrieved from  
http://herb.umd.umich.edu/
Xiao-Tian Liang, Wei-Shuo Fang (editors), Medicinal Chemistry 
of Bioactive Natural  Products (2006), Wiley-Interscience.
Samples of numerous plant species were received from the
southwestern part of the USA from Richard Spjut, and plant
samples were collected here in Illinois. All were extracted with
typical solvents, giving crude residues, some of which were
submitted for anti-TB and/or antibacterial testing. In some cases,
crude extracts were subjected to chromatographic methods.
Some of the fractions were submitted for testing.
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